Stocks
ALX Oncology Holdings (ALXO) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -18.8 | -43.5 | -83.5 | -122.0 | -169.4 | -151.1 | ||
| Changes by years, y/y, % | +42% | +132% | +92% | +46% | +39% | +66.5% | |||
ALX Oncology Holdings. EBITDA US GAAP, bln rub
ALX Oncology Holdings. EBITDA US GAAP, changes, %
ALX Oncology Holdings. EBITDA US GAAP, sum by quarters, bln rub
ALX Oncology Holdings (ALXO) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -50.4 | -44.9 | -34.9 | -38.8 | -32.6 | -151.1 | |
| Changes by years, y/y, % | +38% | +39% | +18% | +15% | -35% | |||
| Changes by quarters, q/q, % | +50% | -11% | -22% | +11% | -16% | |||
